Interstitial Lung Diseases in the Veterans Administration

Robert Tighe

Status: Active, not recruiting

Conditions: Interstitial Lung Disease

Study type: Observational

Funder types: Other U.S. Federal agency; Industry

Identifiers

NCT02479126

01882

Details and patient eligibility

About

The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Interstitial Lung Disease (ILD) ICD-9 code diagnosis 515.0 or 516.3

Exclusion criteria

• Inadequate documentation of patient receiving care for ILD in the health records

Trial design

3,000 participants in 1 patient group

Interstitial Lung Disease

Description:

Patients will be identified from a specified 5 year period based on an International Classification of Diseases-9 (ICD-9) code diagnosis of Interstitial Lung disease (515) or Idiopathic Pulmonary Fibrosis (516.3). The patients will be obtained from the records of the Veterans Integrated Service Network (VISN) 6: VA Mid-Atlantic Health Care Network.